XTL Biopharmaceuticals Ltd (XTLB)
1.71
-0.12
(-6.56%)
USD |
NASDAQ |
Nov 22, 14:21
XTL Biopharmaceuticals Total Assets (Quarterly): 2.928M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.928M |
| December 31, 2023 | 2.426M |
| September 30, 2023 | 2.663M |
| June 30, 2023 | 2.881M |
| March 31, 2023 | 3.322M |
| December 31, 2022 | 4.186M |
| September 30, 2022 | 4.897M |
| June 30, 2022 | 5.757M |
| March 31, 2022 | 6.621M |
| December 31, 2021 | 6.618M |
| September 30, 2021 | 6.855M |
| June 30, 2021 | 6.953M |
| March 31, 2021 | 7.311M |
| December 31, 2020 | 6.503M |
| September 30, 2020 | 6.21M |
| June 30, 2020 | 6.789M |
| March 31, 2020 | 7.269M |
| December 31, 2019 | 7.212M |
| September 30, 2019 | 8.289M |
| June 30, 2019 | 9.548M |
| March 31, 2019 | 12.43M |
| December 31, 2018 | 8.575M |
| September 30, 2018 | 7.469M |
| June 30, 2018 | 6.436M |
| March 31, 2018 | 6.429M |
| Date | Value |
|---|---|
| December 31, 2017 | 6.586M |
| September 30, 2017 | 6.825M |
| June 30, 2017 | 7.172M |
| March 31, 2017 | 7.796M |
| December 31, 2016 | 3.017M |
| September 30, 2016 | 4.056M |
| June 30, 2016 | 4.337M |
| March 31, 2016 | 4.758M |
| December 31, 2015 | 5.323M |
| September 30, 2015 | 7.485M |
| June 30, 2015 | 7.861M |
| March 31, 2015 | 5.013M |
| December 31, 2014 | 5.644M |
| September 30, 2014 | 6.688M |
| June 30, 2014 | 7.224M |
| March 31, 2014 | 7.743M |
| December 31, 2013 | 8.015M |
| September 30, 2013 | 10.28M |
| June 30, 2013 | 9.38M |
| March 31, 2013 | 10.42M |
| December 31, 2012 | 11.09M |
| September 30, 2012 | 7.857M |
| June 30, 2012 | 7.338M |
| March 31, 2012 | 7.863M |
| December 31, 2011 | 4.073M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.426M
Minimum
Dec 2023
7.311M
Maximum
Mar 2021
5.411M
Average
6.356M
Median
Total Assets (Quarterly) Benchmarks
| Compugen Ltd | 123.52M |
| Pluri Inc | 35.44M |
| BioLine Rx Ltd | 64.60M |
| Can Fite Biofarma Ltd | 9.989M |
| BiomX Inc | 59.98M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.223M |
| Shareholders Equity (Quarterly) | 2.705M |